This R&D Briefing summarises the outputs of breakout group discussions held during a CIRS multi-stakeholder workshop in December 2020 entitled ‘Reimagining medicine regulatory models: implementing fit-for-purpose sustainable activities for patient access’. Each breakout focused on one of the below areas and discussed activities that evolved as a result of the COVID-19 pandemic as well as lessons learned that could inform future regulatory models.
If you have any questions or comments on this R&D Briefing, please don’t hesitate to get in touch with Jenny Sharpe: jsharpe@cirsci.org
